Omeprazole Induces CYP3A4 mRNA Expression but Not CYP3A4 Protein Expression in HepaRG Cells.
Unknown interactions between drugs remain the limiting factor for clinical application of drugs, and the induction and inhibition of drug-metabolizing CYP enzymes are considered the key to examining the drug-drug interaction (DDI). In this study, using human HepaRG cells as an in vitro model system, we analyzed the potential DDI based on the expression
Yuto, Fujita +5 more
openaire +1 more source
Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia. [PDF]
Westra N +18 more
europepmc +1 more source
Sustained Drug-Drug Interaction Between Cyclosporine and Apalutamide in a Patient With Metastatic Hormone-Sensitive Prostate Cancer: A Case Report and Evaluation of CYP3A4 Induction via Pregnane X Receptor Activation by Apalutamide. [PDF]
Mimura Y +17 more
europepmc +1 more source
In Silico Comparison of Rifampicin and 25-desacetyl Rifampicin-Induced PXR-Mediated CYP450 Transcriptional Response in 3D Primary Human Hepatocytes. [PDF]
Kahiya ET +5 more
europepmc +1 more source
Development of an Empirical Approach for the Prediction of Cytochrome P450-Based Drug-Drug Interactions in Pediatric Patients. [PDF]
Di Paolo V +3 more
europepmc +1 more source
Deconvoluting Gut Versus Liver Cytochrome P450 3A4 Function: Drug Probes, Biomarkers, and Tissue Biopsy. [PDF]
Rodrigues D.
europepmc +1 more source
Chimerism and clonal exhaustion [2] (multiple letters) [PDF]
Bishop, GA +4 more
core +1 more source
Donor and recipient genetic polymorphisms modulate tacrolimus pharmacokinetics during voriconazole co-therapy: a drug-drug interaction study in liver transplant recipients. [PDF]
Li J +9 more
europepmc +1 more source

